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Troca valvar aórtica com diferentes próteses. Existem diferenças nos resultados da fase hospitalar?
Aortic valve replacement with different types of
prosthesis. Are there differences in the outcomes
during hospital phase?
Abstract
Objective: To analyze intraoperative data and possible
differences in clinical evolution during postoperative
hospital phase for aortic valve replacement surgery using
different types of prosthesis.
Methods: Analysis of 60 patients divided into three groups.
Valve replacement with bioprosthesis (20), mechanical
prosthesis (20) and homologous valve (20). The mean age
was 51.1, 60% were male and 40% female patients; 86.7 %
were in NYHA II or III; 63.3% presented arterial
hypertension and 18.3% had diabetes. Aetiology of valve
disease was degenerative for 39%, rheumatic for 36% and
endocardits for 15%.
Results: The hospital mortality was 5%; there were no
differences in the incidence of septical or cardiogenic shock,
acute renal failure, rhythms disorders during surgery or
intensive care, neither for total time in intensive care and
mechanical ventilation. However, there was statistical
differences as regards the cardiopulmonary bypass total time
(P=0.02) and the aortic clamping time (P<0.0001) unfavorable
to homograft valve group. The ward admission time was
greater for mechanical valve group (P=0.05) as well as for
total admission time, but without statistical significance. It
was observed that patients with preoperative hematocrit
smaller than 38.1% used 2.73 units of blood components,
and with postoperative hematocrit smaller than 32% used
1,79 units of blood components. Echocardiography control
showed minimal evolutional differences.
Conclusion: The use of different types of prosthesis for
this study does not cause differences in the results of
postoperative hospital phase. The use of homograft valve is
a feasible option with good clinical applicability.
Descriptors: Heart valve diseases. Aortic valve/surgery.
Transplantation, homologous.  Cardiac surgical procedures.
Resumo
Objetivos: Analisar dados intra-operatórios e possíveis
diferenças na evolução clínica da fase hospitalar de pós-
operatório da troca valvar aórtica com diferentes próteses.
Métodos: Análise de 60 pacientes, divididos em três grupos:
os submetidos a troca valvar por prótese biológica (20); por
prótese mecânica (20); e finalmente, por valva homóloga (20).
A média da idade foi de 51,1 anos; 60% eram do sexo
masculino e 40% do feminino; 86,7% estavam em NYHA II
ou III; 63,3% eram hipertensos, 18,3% diabéticos; a etiologia
valvar foi degenerativa em 39%, reumática em 36% e
endocardite em 15%.
Resultados: A mortalidade hospitalar foi de 5%; não houve
diferenças entre os grupos na incidência de choque séptico
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INTRODUCTION
In Brazil, the biological prosthesis has been the most
used replacement valve. We see this preference for
countless reasons, such as patient’s socioeconomic
condition, and cases when there is no need for life-long
anticoagulation. These prostheses have evolved in our
country, beginning with the biological tissues of dura mater,
as published by Puig et al. [1,2], and shifting to bovine
pericardium and porcine valves made into rings [3,4].
Undoubtedly, since the first replacement valves were
produced by Hufnagel in the 1950s, there has been great
technological change provided by several researchers and
many marketable prostheses [3,4].
Bioprostheses in general present low thrombogenicity,
good hemodynamics, and no noise in the postoperative
and, due to their central flow, low turbulence. However, the
limitation for their use is directly related to their durability
and calcification issues, as well as a need for reoperation
with increased surgical risk [4,5].  But they are often
recommended, especially in the elderly and those unable
to undergo an anticoagulation regime.
Various types of mechanical prostheses are widely used
when they meet the criteria, albeit ever-changing criteria.
They are an option for valve replacement in young  adults
and children who have the disadvantage of rapid structural
degeneration with bioprostheses coupled with somatic
growth. Double-leaflet mechanical prostheses are widely
used, have good hemodynamics, a low profile, good
durability, and reduced incidents of thrombosis and
thromboembolic phenomena, especially if the
anticoagulation protocol is used under strict control [5].
Usually, limitations result from the use of anticoagulants,
and a small volume of bleeding can occur, as well as severe
cases of stroke, thrombosis on the prosthesis, hemolysis,
fracture, and occluder wear and tear.
The homologous or homograft valve, which seems to
be less vulnerable to infection, has good hemodynamic
and recovery to the normal flow in the aortic root and
coronary sinus. It is also presents acceptable gradients in
the postoperative period [6]. Due to the lack of donors and
the difficulty of sterilization and storage, some limitations
to the use of such prostheses may occur, leading
researchers to test tissue from animals such as pigs, sheep
and calves [3]. There are also reports of early changes in
the valve because of poor commissural alignment and
distortion, causing early aortic insufficiency caused by the
surgical technique [6]. Nationally, there are still few centers
with experience or routine use of homografts.
Despite different characteristics, such as flow, area,
gradients and durability, the type of prosthesis must be
chosen carefully, and is generally influenced by the team’s
experience. This choice is always made after an assessment
of the patient’s clinical status, socioeconomic and
psychological aspects, age, disease history and the
possibility for frequent medical follow-up in the
postoperative period.
The aim of this study was to establish whether there are
variables in the hospital phase that could influence the
choice of prosthesis (apart from those that are clearly
established and discussed in the literature regarding
decision-making in advanced stages of diseases [7-10]).
We also analyzed some hemodynamic variables during




In the Dr. José Pedro da Silva Cardio-Surgical Clinic of
São Joaquim da Real and the Benemérita Associação
Portuguesa de Beneficência of São Paulo, a cross-sectional
study was performed, with an analysis of the records of 60
patients who underwent aortic valve replacement.
We selected 20 patients from a total of 35 who received
homologous valve operations from our team between the
years 1995 and 2003, because the medical records of these
ou cardiogênico, insuficiência renal aguda, arritmias no
centro cirúrgico e na unidade de terapia intensiva (UTI), assim
como para o tempo de internação na UTI e tempo de ventilação
mecânica. Houve diferença estatística nos tempos de
circulação extracorpórea (P=0,02) e pinçamento aórtico
(P<0,0001) desfavorável aos pacientes com valva homóloga.
O tempo de internação na enfermaria foi maior para os
pacientes com valva mecânica (P=0,05), assim como o tempo
total de internação hospitalar tende a ser maior neste grupo,
porém sem significância estatística. Pacientes com
hematócrito pré-operatório abaixo de 38,1% utilizaram 2,73
unidades de hemoderivados; e com hematócrito no pós-
operatório abaixo de 32% utilizaram 1,79 unidades. Controle
ecocardiográfico mostrou mínimas diferenças evolutivas.
Conclusão: A utilização de diferentes próteses, nesta
amostra, não gerou diferenças nos resultados da fase
hospitalar de pós-operatório; O homoenxerto é uma opção
viável e com boa aplicabilidade clínica.
Descritores: Doenças das valvas cardíacas. Valva aórtica/
cirurgia. Transplante homólogo. Procedimentos cirúrgicos
cardíacos.
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patients contained all of the variables that the researchers
intended to study. From the 200 consecutive patients
receiving a valve replacement using bovine pericardial
biological prostheses, which were included in the team’s
database, 20 patients were randomly selected. For this, we
used the function Random ( ) within the Microsoft Excel
2003 software. Similarly, another 20 patients who had
received a valve replacement using a double-leaflet
mechanical prosthesis were randomly selected. Thus, we
obtained the same number of patients per group.
The homologous valve was removed from the donor’s
heart (the hearts would not be used for transplant because
of standards set and met by the regulatory center for the
donation of organs and tissues, obeying the current
legislation). These valves were stored in a solution
containing an antibiotic with spectrum against Gram-
negative and Gram-positive, and cooled in an appropriate
place for the maximum time determined by the team 48 hours
after the removal.
24 patients were female (40%) and 36 (60%) were male,
with ages ranging from 12 to 90 years old with mean of 51.1
years for all groups involved (biological, 59.2 years old;
mechanic, 43.8 years old; and homologous, 50.3 years old).
The distribution of weight ranged from 42 to 98 kg, with a
mean of 68.8 kg. The patients’ heights ranged from 1.45 to
1.86 meters with a mean of 1.67 meters.
Among the patients analyzed, 63.3% presented with
hypertension, and 18.3% had diabetes. 32.7% presented
with some type of dyslipidemia, and 41.7% were smokers.
The etiology of valve disease was the predominantly
degenerative in 39% of the cases. It was rheumatic in 36%,
and 15% were determined to be infective endocarditis. The
etiology was not found in 10% of the records. The primary
valve lesion was pure aortic stenosis with some cases of
such lesion in patients with biological and mechanical valve
and pure aortic insufficiency and primary in the homologous
group. Among the patients studied, 90% presented sinus
rhythm. The mean of hematocrit count in the preoperative
was 40.1%.
At the time of surgery, functional class according criteria
of the New York Heart Association (NYHA) was II in 55%
of cases and III in 31.7% of cases, and the ejection fraction
in the preoperative (using the cube method) ranged from
37% to 84%, with a mean of 67.2% for all patients.
Neither re-operated patients nor those who underwent
associated surgical procedures were excluded from the
study. A total of 12 patients (20%) had previously undergone
valve replacement. The most frequent procedures
associated were CABG, aortic annulus enlargement and
mitral repair. There were seven patients in the biological
group and seven patients in the homologous group
underwent associated procedures, as well as four patients
in the mechanical group.
All patients underwent cardiopulmonary bypass (CPB)
using a membrane oxygenator, moderate hypothermia (32
to 28ºC) and myocardial protection with hypothermic
antegrade/retrograde blood cardioplegia, according to type
of valve lesions and the surgical team’s preference.
For statistical evidence, analysis of variance (ANOVA)
was used to test effects and compare mean values of
various parameters in the three groups when there was a
parametric distribution; non-parametric ANOVA was used
for groups of data with non-Gaussian distribution; the
Student t-test was also used for comparisons of means
between groups; the simple linear regression model was
used to identify relationships between variables and chi-
square test for testing of equality between proportions
when it is considered more than two groups simultaneously.




The mortality of the sample in the period studied was
5% (three patients). There was one patient who had
undergone valve replacement using homologous valve due
to late endocarditis of biological prosthesis and underwent
reoperation. This patient died due to cardiogenic and septic
shock in the intensive care unit (ICU). The other two
patients underwent valve replacement using biological
prosthesis, and also underwent reoperation due to
endocarditis of late biological prosthesis. They died of
septic shock.
The group with the lowest mean age was the mechanical
valve group. However, the mean age of this group was
only statistically significant when compared to the group
with biological prosthesis replacements (P=0.03), and didn’t
interfere with the overall analysis of the sample.
Regarding the occurrence of shock in the ICU, it is noted
that there was no difference in the occurrence of cardiogenic
shock (P=0.76) and septic shock (P=0.34) when measured
in terms of type of prosthesis used. Cardiogenic shock
occurred in two patients from the biological prosthesis
group, one patient from the mechanical prosthesis group,
and one from the homologous prosthesis group. Septic
shock affected two patients undergoing replacement valve
using biological prosthesis and two patients undergoing
replacement using homologous valve.
 The cardiac rhythm in the preoperative in 54 patients
(90%) was sinus. There were four (6.7%) with atrial fibrillation
(AF), one (1.6%) with a permanent pacemaker and another
(1.6%) in atrial rhythm. The postoperative cardiac rhythm
changed after surgery, with 45 (75.5%) patients in sinus
rhythm, four (6.7%) in AF, one (1.7%) with a pacemaker, one
( 1.7%) in the infra-Hissian scape rhythm, seven (11.7%) in
atrial rhythm and two (3.3%) in junctional escape. These
changes had equivalent distribution for the three groups.
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Researchers also studied the occurrence of supra-
ventricular and ventricular arrhythmias in the surgical center
based on type of prostheses. They defined as significant
those arrhythmias that cause hemodynamic instability, a
need for the use of antiarrhythmic agents and cardioversion
and/or defibrillation procedures after removal of CPB
cannulas. There was equality in the proportion of patients
who suffered arrhythmias for the three types of prostheses
(P=0.13). Similarly, there was equality between the three
groups in the proportion of patients who suffered
arrhythmias in the ICU (P=0.21) with some kind of
intervention (chemical or electrical).
We analyzed the use of catecholamines and vasoactive
drugs by the type of prosthesis in the operating room and
ICU. According to the data, there was a predominance of
dobutamine and sodium nitroprusside used in the three
groups, with no statistical differences in the use of such
drugs by groups in the sample studied.
The total time of surgery was equal for both genders
(P=0.48) and for the three types of prosthesis implanted
(P=0.07).
Figure 1 presents the descriptive measures of time
of CPB (minutes) by group. There was a statistically
significant difference between the types of prostheses
used, with more CPB time for patients who had
undergone homologous valve implants (P=0.02); there
were no significant differences between genders
(P=0.32). The time of aortic clamping (minutes) by
gender was not different (P=0.71), but there are again
clear and important statistical differences between the
types of prostheses used (P<0.0001), caused largely
by the longer length of CPBs in the homologous group,
as shown in Figure 2.
 During analysis, it was found that mediastinal stroke
assessed by echocardiography in the postoperative period
(ranging from moderate to severe) occurred at the same
rate among the three groups (P=0.64). The rates were also
the same for pleural effusion (P=0.88). There were four
patients with mediastinal effusion in the biological and
mechanical prosthesis groups and three patients in the
homologous valve group (not everyone needed
intervention).
Was also analyzed the percentage of patients who
returned to the operating room in each group; there was,
again, equality among the three types of prostheses
(P=0.36). The cause of the return to operating room was
hemostasis review for one patient from the mechanical
prosthesis group, two patients from the biological prosthesis
group, and one from the homologous prosthesis group.
Two patients from the biological prosthesis group and one
patient from the homologous group also returned to the
operating room so that surgeons could drain the
mediastinum after severe effusion.
 The use of blood derivatives (concentrated red blood
cells, platelets, crioprecipitate and fresh human plasma) was
tested, and was affected by hematocrit counts in pre-and
postoperative period. It was noted that the relationship
between a preoperative hematocrit count below 38.1%  and
the use of a blood derivative is significant (P = 0.03), and
these patients used at least 2.73 units of blood derivatives
compared to patients on which hematocrit counts above
38.1% (95% CI: 1.70; 3.76). The same fact occurs for
Fig. 1 - Mean time of cardiopulmonary bypass (CPB) in minutes
with standard deviation for different types of prostheses. Through
analysis, we note that there is a difference with statistical significance
that disfavors the homologous valve group. We used the non-
parametric ANOVA test
Fig. 2 - Mean time of aortic clamping in minutes with standard
deviation for different types of prostheses. Through analysis, we
note that there is difference with statistical significance that
disfavors the homologous valve group. We used the non-
parametric ANOVA test
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hematocrit counts below 32.0% in the postoperative period
(p=0.01) - these patients used at least 1.79 units of blood
derivatives (95% CI: 1.14; 2.44). There were no differences
in the sample among the three groups in the general use of
blood derivatives in the operating room and ICU, nor in the
absolute values of bleeding by the mediastinal drain
postoperatively. The red blood cell concentration was the
most commonly used blood derivative in all groups.
Assessing other factors related to the ICU, there is
equality in the time of mechanical ventilation with respect
to gender (P=0.56) and type of prosthesis (P=0.32), showing
that there were no significant statistical differences between
the three studied groups. In relation to the total time in ICU
(Table 1), there were no significant differences with respect
to gender (P=0.73) or the type of prosthesis (P=0.27).
Regarding the incidence of acute renal failure in the
ICU, it was found that there were no differences in incidents
of acute renal failure (P=0.77),  or the need for dialysis
(P=0.86) between the groups. From the homologous valve
group, three patients presented acute renal failure, and one
underwent dialysis and died; from the biological prosthesis
group, three patients presented acute renal failure and two
went on dialysis. Finally, from the mechanical prosthesis
group, two patients presented acute renal failure and one
needed dialysis.
 The time of hospital stay in the recovery ward did not
favor the patients who underwent mechanical valve
replacement (P=0.05). Analyzing Table 2, we find that the
patients in this group presented a higher average hospital
stay than the other groups. This data also increased the
total time of hospital stay for the mechanical valve group in
relation to the two other studied groups (P=0.57), but
without statistical significance.
The effect of a patient who returned to the ICU on the
total time of hospital stay was also assessed. Note that
there is a difference in the total time of hospital admission
with regard to the need for readmission to the ICU
(P<0.0001); thus, the total time of hospital stay of those
who returned to the ICU is, on average, 8.7 days longer
than the time of stay for those who did not return. However,
the occurrence of returning to ICU by type of implanted
prosthesis was not different, and was not significant among
the three groups (P=0.77). The most common reason for
returning to the ICU was acute AF, followed by failure or
respiratory distress.
We also assessed some pre- and postoperative
echocardiographic variables. Regarding ventricular
diameters, it is noted that there were evolutive differences
expected in this phase of admission, though they were not
statistically different between the types of prostheses used
(P=0.73). The mean preoperative left ventricle end-diastolic
diameter was 54.8 mm for the biological replacement group,
64.6 mm for the mechanical prosthesis group, and 64.4 mm
in the homologous prosthesis group. There was
improvement in the postoperative period, with the mean
falling to 49.2 mm for the biological prosthesis group, 55.2
mm for the mechanical prosthesis group, and 58 mm in the
homologous prosthesis group. The left ventricle end-
diastolic volume (LVEDV) and left ventricular end systolic
volume (LVESV) were tested, and we found no statistical
differences by group in the postoperative when compared
to values in the preoperative (P=0.35 P=0.59), but with a
tendency toward an evolutive improvement, especially in
cases of aortic valve insufficiency.
We also assessed the descriptive measures in ejection
fraction (EF) according the pre- and postoperative cube
method measurements by types of prostheses, with no
differences between groups (P=0.66). However, in relation
to the postoperative EF, there was a significant difference
between different types of prostheses. There was an increase
in postoperative EF - it was higher for patients in biological
prosthesis group and lower for patients in the mechanical
prosthesis group (P=0.01). Possible reasons will be discussed
later. Table 3 presents the descriptive EF measures for the
pre-and postoperative periods using the cube method. The
measurement of the aorta diameter in the pre- and
postoperative periods was also analyzed by group, and we
noted the absence of evolutive differences according to the
type of prosthesis (P=0.59), as well as for left atrial dimension
and the aorta/left atrial relationship (P=0.53 and P=0.58).
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Earlier this decade, in a multicenter study involving the
use of the Carpantier-Edwards bovine pericardial
prostheses (Perimount), Marchand et al. [11] showed 37.1%
of actuarial survival, with 68.8% free of structural
dysfunction in 14 years in the atrioventricular position.
Regarding this frequent late complication that occurs
primarily in young, MyKen et al. [12] published a good
sample with porcine bioprosthesis and satisfactory
evolution over 15 years, and a survival rate of 41% in the
aortic position, especially in the adult population. Studies
also performed by Braile et al. [4] at Incor, Clinic Hospital of
the Faculty of Medicine of the University of São Paulo
(HC-FMUSP) with bovine pericardial bioprostheses (even
in patients over 70 years) [2,14] showed results similar to
the international literature; with excellent results after 12
years of follow-up.
According to Lund et al. [15] and Jamieson et al. [16],
under late postoperative period analysis, double-leaflet
mechanical prostheses also have low mortality rates related
to the valve, low thrombogenicity, hemolysis rate and
absence of mechanical failure over 18 years of follow-up,
especially when associated with rigorous anticoagulation
protocol.
 Regarding the aortic homograft, there is the study of
O’Brien et al. [17], with a sample of 1,022 patients over 29
years of follow-up and survivals free of reoperation in 50%
of the patients over 20 years. Similar results were seen in
the study by Sadowski et al. [18], who reported on 655
patients over 23 years and 49.5% of survivals free of
reoperation over 20 years.
The results presented in this study relate to the patients’
postoperative time in the hospital - the time of hospital
admission until the patient’s discharge - and, as previously
mentioned, we did not find any other similar comparisons
of the three types of prostheses for that specific period in
the literature.
The results presented herein in relation to overall
mortality of the groups showed no statistically significant
differences due to the extent of the sample. We emphasize
the high morbidity and mortality, with survival that may be
less than 50% in aortic valve replacements in the presence
of infected endocarditis associated with acute aortic
insufficiency, acute renal failure and congestive heart failure
[19]. This combination can be seen in severe cases of aortic
ring abscesses, which are generally difficult to treat, which
led researchers [20] to search for new techniques to
enhance and improve  surgical outcomes.
There were cardiac rhythm changes in all groups during
the postoperative period. These changes were related to
surgical manipulation of the heart and sutures that are in
close relationship with the path of the conduction system,
in addition to the aortic ring’s impairment. However, these
findings are described in the postoperative of aortic valve
replacements, especially in the presence of endocarditis
[21], and, in most cases spontaneous reversion to the
preoperative rate can occur. This usually occurs after
improvement of the local inflammatory process and
reduction of edema.
The times of aortic clamping and CPB were higher for
the homologous valve group, and these findings were
expected because the surgical technique of the implant
procedure of this valve is more delicate and laborious than
the bioprosthesis or the mechanical valve, with possible
occurrence of early aortic insufficiency during
postoperative, as shown by Staab et al. [6]. This fact was
not noted in echocardiographic control of the studied
group. The total time of surgery did not negatively affect
the results and statistical significance to the homologous
valve, because the other groups were related to greater
number of associated procedures.






















































Table 3. Descriptive measurements of the pre- and postoperative
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The time of stay in the recovery ward was higher for the
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implanted through new techniques.
LIMITATIONS
 
A sampling of 60 patients, 20 per group, was a limiting
factor for this study.
 
CONCLUSION
The results of the clinical patient’s evolution in the
hospital phase of postoperative was not affected by
different types of prostheses used in the study despite
some variables which have statistical significance, such as
increased surgical time (CPB and clamping) in those
patients who used homologous valve. The time of hospital
stay in patients who had undergone mechanical valve
replacement tends to be longer to achieve appropriate
anticoagulation control.
The use of the aortic homograft is a viable option, with
good clinical applicability in various cases, especially in
infections of the aortic valve or prosthesis.
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